Precision Medicine: Is It a Must, a Bust—or Something in Between?

Two new articles give completely different perspectives on the value of precision medicine. In the case of myeloma, precision medicine means the development of new, targeted therapy based upon specific gene mutations in the myeloma. A review article in Science lists the “Ten things we have to do to achieve precision medicine” and gives a sense of optimism that, although there are challenges, it is only a matter of time before the advent of precision medicine.